Intranasal Dexmedetomidine for Sedated Hearing Testing
NCT03530371
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Auditory Brainstem Response
Interventions
DRUG:
Dexmedetomidine Hydrochloride
Sponsor
Fondation Lenval